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INTRODUCTION
Pain in the region of the pes anserinus (PA) insertion is a
common rheumatologic condition diagnosed as pes anserinus
tendinitis or bursitis (PATB) syndrome. Its diagnosis is entire-
ly based on clinical manifestations, which is marked by spon-
taneous medial knee pain on climbing or descending stairs,
tenderness at the PA insertion, and occasionally local swelling
(1). The anserine bursa lies underneath the PA, the name
given to the conjoined tendon of the sartorius, gracilis, and
semitendinosus muscle at its insertion into the upper medi-
al aspect of tibia, about 5 centimeters distal to the medial
aspect of the knee joint (2). PATB syndrome is frequently
associated with osteoarthritis (OA) and vice versa. In a pre-
vious report, anserine bursitis was clinically diagnosed in 29
(46.8%) among 62 Korean patients with knee OA (3). In
contrast, 20 (83.3%) among 24 PATB patients were report-
ed to have radiographic evidence of knee OA (4). As a result,
it has been taken for granted that “Pain of OA could have a
cause due to periarticular problems, such as anserine bursi-
tis” (5). In addition, PATB syndrome is also associated with
obesity or type II diabetes mellitus (DM) (2, 6).
Ultrasonographic (US) evaluation is useful for diagnosing
a variety of regional pain syndrome and soft tissue rheuma-
tism and has been increasingly employed in the rheumato-
logic practice. The objectives of this study were to assess the
US findings in patients with knee OA with PATB syndrome
and to determine the correlation between the US findings
and the response to local corticosteroid injection.
MATERIALS AND METHODS
We prospectively studied 26 patients with knee OA diag-
nosed at a University affiliated rheumatology clinic (all women,
mean age 63.4 yr, range 53-77). Sex, age, height, weight, body
mass index, and radiographic knee osteoarthritis graded I-IV
according to Kellgren and Lawrence (7) were recorded. 
PATB syndrome was clinically diagnosed, as described pre-
viously with minor modification (6). Briefly, each patient
completed a questionnaire regarding knee pain as follows:
1) Have you had knee pain in the last 2 weeks? 2) Does your
knee hurt when ascending or descending stairs? 3) Does your
knee hurt when performing weight bearing activity? 4) Do
you have trouble getting out of a car? All of the patients under-
went a complete history and examination, including deep
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Correlation between Ultrasonographic Findings and The Response to
Corticosteroid Injection in Pes Anserinus Tendinobursitis Syndrome in
Knee Osteoarthritis Patients
The objectives of this study were to assess the ultrasonographic (US) findings in
patients with knee osteoarthritis (OA) with pes anserinus tendinitis or bursitis (PATB)
syndrome and to determine the correlation between the US findings and the res-
ponse to local corticosteroid injection. We prospectively studied 26 patients with
knee OA with clinically diagnosed PATB syndrome. A linear array 7 MHz trans-
ducer was used for US examination of the knee. Seventeen patients were injected
locally with tramcinolone acetonide in the anserine bursa area. Response to local
corticosteroid injection was evaluated by pain visual analog scale (VAS), Western
Ontario and MacMaster (WOMAC) osteoarthritis index and Global patient/physi-
cian assessment using Likert scale. On US examination, only 2 patients (8.7%)
showed evidence of PATB. Pain VAS, WOMAC pain index and WOMAC physical
function index improved significantly after corticosteroid injection. Global patient
assessment revealed that 2 patients showed best response, 6 good, 1 fair, 8 the
same, and none worse. It is of note that the 2 patients who showed the best
response were those who showed US evidence of PATB. This finding shows that
US can serve as a useful diagnostic tool for guiding treatment in PATB syndrome
of OA patients.
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palpation of the anserine bursa at the same location over the
medial aspect of the tibia below the knee joint. PATB syn-
drome was diagnosed if the patient responded positively to
the questionnaire 1) and one of 2), 3), or 4) and tenderness
was elicited on examination of anserine area. 
Patients with the clinical diagnosis of PATB syndrome were
enrolled into the US study. For the purpose of comparison
between symptomatic and asymptomatic side, patients who
complained of tenderness in only one anserine area were in-
cluded. A linear array 7 MHz transducer (HDI 5000, ATL
ultrasound, Bothell, WA, U.S.A.) was used. US examination
of the knee and PA was performed as previously reported
with minor modification by a radiologist trained in muscu-
loskeletal US (8). The PA was located 2.5-3 cm distal to the
medial joint line with the transducer placed longitudinally.
The following US examinations were performed: measure-
ment of the thickness of the PA (mean of 3 measures); mor-
phologic intratendinous PA tissue characteristics; presence of
anserine tendinitis (both thickening and loss of normal fib-
rillar echotexture); presence of bursitis (circumscribed ane-
choic fluid collection of 2 mm or greater). 
Seventeen patients were injected locally with triamcinolone
acetonide in the anserine bursa area. A mixture of 40 mg tri-
amcinolone acetonide and 1 mL of 2% lidocaine was infiltrat-
ed at the point of maximal tenderness in the anserine bursa
area. Response to local corticosteroid injection was evaluat-
ed by pain visual analog scale (VAS) related to the knee and
Global patient/physician assessment using Likert scale 2 weeks
after corticosteroid injection (0=best response, complete relief
of pain, 1=good response, pain decreased markedly, but pain
remains, 2=fair, pain decreased slightly, 3=the same, pain
was the same as that before the treatment, 4=worse, pain was
worse than that before the treatment). Culturally adapted and
validated Korean version of Western Ontario and MacMaster
(WOMAC) osteoarthritis index was also used (9). 
Data are presented as mean±S.D. for continuous variables
and as frequency (%) for categorical variables. A p-value was
calculated by Student’s t-test for continuous variables or by
chi-square test for categorical variables. A p value of p<0.05
was considered statistically significant and all the statistical
analyses were performed using SPSS for Windows (Version
10.0, Chicago, IL, U.S.A.).
RESULTS
Table 1 shows baseline demographic characteristics of the
subjects. 
On US examination, only 2 patients (7.7%) showed US
evidence of PATB. In one patient, marked thickening and
loss of normal fibrillar echotexture of symptomatic side com-
pared to asymptomatic side was observed (Fig. 1). In the other
patient, anechoic fluid collection in the symptomatic anserine
bursa area was noted (Fig. 2). Positive US finding of PATB
did not correlate with age, duration of osteoarthritis, body
mass index or radiographic grading of OA. The thickness of
PA tendon was significantly greater in symptomatic side com-
pared to asymptomatic side, but when the 2 patients with
US evidence of PATB were excluded, the difference was not
statistically significant (Table 2). Other US findings in these
patients included the following : suprapatellar pouch effusion
22 (84.6%), degenerative spur change 16 (61.5%), popliteal
cyst 4 (15.4%), infrapatellar bursitis 1 (3.8%). Superficial
patellar bursitis was not found in any of our patients. 
Local corticosteroid was injected in 17 patients. The demo-
graphic and clinical characteristics of these 17 patients were
not different from those of 9 patients who were not injected
with corticosteroids except that those who were injected were
older than those who were not injected (Table 1). Pain VAS
significantly decreased from 73.1 mm before corticosteroid
injection to 50.7 mm after injection (p=0.0004, Table 3).
WOMAC pain index and WOMAC physical function index




injected (n=17) not injected (n=9) positive (n=2) negative (n=24)
Age (yr) 63.4±7.0 65.3±7.3 60.0±5.1 57.0±5.7 64.0±7.0
Body weight (kg) 60.4±7.9 60.0±9.4 61.1±4.0 60.5±10.6 60.0±9.4
Height (m) 1.52±0.07 1.51±0.07 1.53±0.07 1.57±0.11 1.51±0.07
Body mass  index (kg/m
2) 26.1±2.9 26.1±3.5 26.1±1.3 24.4±0.8 26.4±3.5
Disease  duration (months) 93.6±107.5 85.4±111.6 109±104.0 2.5±2.1 96.5±111.6
K-L grade ≥3 (%) 65.4 58.8 77.8 50.0 60
Table 1. Baseline demographic characteristics of the subjects
Fig. 1. Ultrasonographic finding of tendinitis in the pes anserinus.
Marked thickening of symptomatic side compared to asymptomat-
ic side is observed along with loss of normal fibrillar echotexture.
5 mm Right Left 3.5 mmalso improved significantly after corticosteroid injection (10.6
and 33.8 before corticosteroid injection and 7.5 and 27.4 after
injection, p=0.007 and 0.006, respectively). Global patient
assessment using Likert scale revealed that 2 patients showed
best response, 6 good, 1 fair, 8 the same, and none worse (Table
4). Global physician assessment revealed that 2 patients show-
ed best response, 4 good, 5 fair, 1 the same, and 5 worse. It
is of note that the 2 patients who showed the best response
were those who showed US evidence of PATB. It is also of
note that after the corticosteroid injection, tenderness on deep
anserine palpation disappeared in only 5 patients (29%) in-
cluding the 2 patients that showed US evidence of PATB. 
DISCUSSION 
Currently, it is a common practice to diagnose soft tissue
rheumatic problem clinically and to treat it empirically, some-
times using local corticosteroid injections. Many of these soft
tissue rheumatic problems, however, are elusive to diagnose
by imaging modalities or pathological examination. Previous
reports on radiographic finding of PATB are rare. In a report
by Hall and Joffe (10), computed tomography (CT) imaging
revealed a sharply defined low-attenuation cyst lying imme-
diately beneath the pes anserinus tendon in a patient with
non-tender mass on the anteromedial aspect of the leg below
knee. The mass was not enhanced after injection of intravenous
contrast material. Notably, the authors pointed out that dis-
tension of the anserine bursa is not synonymous with the clin-
ical syndrome of anserine bursitis, because the case patient
did not have any symptoms pertaining to the knee, and that
the clinical syndrome of anserine bursitis actually may be a
tendinitis or a fascitis involving the insertions of the pes anser-
inus tendon. In another report, anserine bursa was visualized
both by ultrasonography and CT (11). In accordance with our
result, ultrasonography demonstrated a cystic mass located
on the anteromedial surface of the proximal tibia. CT guid-
ed aspiration of bursa was perfomed along with intrabursal
injection of methylprednisolone, which led to resolution of
symptoms. Few studies systematically elucidate the morpho-
logical characteristics of the PA insertion and bursa in clinical-
ly diagnosed PATB syndrome by imaging modalities. Because
US examination is an excellent and a widely used technique
for imaging superficial soft tissues, it can be routinely used
as a diagnostic tool to improve the assessment of joints and
soft tissues. One study examined US features of the PA and
subcutaneous medial knee fat in patients with clinically diag-
nosed PATB syndrome (8). Of 37 patients, anserine bursitis
was diagnosed in only 3 knees and PA tendinitis in 1. Another
study which systemically assessed the musculoskeletal US find-
ings in patients with type 2 diabetes mellitus (DM) showed
that 28.6% of clinical PATB syndrome had PA tendinitis
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p=0.03 by paired t-test. p=0.11 by paired t-test.
Symptomatic knee Asymptomatic knee
(n=26) (n=26)
All patients 3.01±1.07 mm* 2.67±0.77 mm




Table 2. Mean thickness of the pes anserinus
p<0.05 by paired t-test.
Before treatment (n=17) After treatment (n=17)
WOMAC 47.9±16.6 37.2±17.6*
subscale
pain 10.6±3.8 7.5±4.2* 
stiffness 3.5±2.5 2.4±2.1 
physical function 33.8±11.7 27.4±12.3* 
Pain VAS (mm) 73.1±18.6 50.7±21.5*
Table 3. Response to local corticosteroid injection in knee os-
teoarthritis patients with clinical pes anserinus tendinobursitis
syndrome
Global patient assessment Global physician assessment
(n=17, %) (n=17, %)
Best 2 (11.8) 2 (11.8)
Good 6 (35.2) 4 (23.5)
Fair 1 (5.9) 5 (29.4)
The same 8 (47.1) 1 (5.9)
Worse 0 (0) 5 (29.4)
Table 4. Response to local corticosteroid injection in knee os-
teoarthritis patients with clinical pes anserinus tendinobursitis
syndrome (global patient and physician assessment)
Fig. 2. Ultrasonographic finding of anserine bursitis. Anechoic fluid
collection measuring 13 mm in maximal diameter is noted.
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findings (12). In line with these reports, our study showed
that only a minority of clinically diagnosed PATB syndrome
patients had US evidence of PATB. This discrepancy between
clinical and US findings could be explained in 3 different ways.
First, US examination may not delineate the PA tendon abnor-
malities involved in the PATB syndrome. In this regard, a
corroboration with magnetic resonance imaging (MRI) would
be intriguing. However, because tissues with few mobile pro-
tons emit little or no signal and therefore the internal archi-
tecture of the tendon may not be well demonstrated by MRI,
this limitation in visualization of tendon abnormality may
also happen with MRI. Second, the tenderness elicited by
deep palpation of anserine area may not stem from PA tendon
or anserine bursa, but from other structures not adequately
visualized by US. In our patients, the most common US find-
ing was suprapatellar effusion followed by degenerative spur
change, all of which are primary findings of underlying knee
OA. Small numbers of patients had popliteal cyst, and infra-
patellar bursitis, but these lesions are not likely to be respon-
sible for the tenderness around the anserine area in the major-
ity of our patients. Third, the point of tenderness by deep
palpation may be another tender point with unusually low
threshold for perception of tenderness. For instance, about
30% of normal controls elicited tenderness on deep palpa-
tion of anserine area (unpublished observation). 
There are a paucity of data regarding the effectiveness of
local corticosteroid injection in patients with PATB syndrome.
In a report by Larsson and Baum (13), there was a significant-
ly better result when steroids were used compared to when
lidocaine alone was used 1 month after the injections. Seven-
ty-one percent of patients injected had improved significant-
ly after a follow up of 2-61 months. However, another report
revealed that only 24% of patients showed good response
and among these only a third experienced total relief of pain
(14). This discrepancy probably results from the differences
in methodology, such as retrospective or prospective design,
or the definition of response. 
Although pain VAS and WOMAC index improved signifi-
cantly in our patients after injection, less than half of patients
responded that they had more than good response and only
11.8% reported complete relief of their discomfort. Because
all of our patients had knee OA, relief of symptoms of PATB
alone may not be sufficient for alleviation of knee discom-
fort. In addition, WOMAC scale has not been validated for
the assessment of symptom change in PATB syndrome pre-
viously. Despite this limitation, it is of note that only those
patients who had US evidence of PATB showed complete
relief of discomfort after corticosteroid injection.
In conclusion, among knee OA patients with clinically
diagnosed PATB syndrome, only a minority had US findings
indicative of PATB. Local corticosteroid injection resulted
in complete relief of pain only in those patients with US find-
ings of PATB. Recently, evidence that US exam can serve as
a useful tool to determine the usage of non-steroidal anti-
inflammatory drug versus acetaminophen in knee OA has
been suggested (15). Also for optimal management of soft
tissue problems in knee OA, assessment by imaging modal-
ities such as US examination is useful. 
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